794 related articles for article (PubMed ID: 16159435)
1. [Detection of sentinel lymph node in patients with early stage breast cancer].
Tang J; Yang MT; Fan W; Wang X; Zhang X; Liang XM; Wang X; Xie ZM
Ai Zheng; 2005 Sep; 24(9):1111-4. PubMed ID: 16159435
[TBL] [Abstract][Full Text] [Related]
2. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node pressure in breast cancer.
Nathanson SD; Mahan M
Ann Surg Oncol; 2011 Dec; 18(13):3791-6. PubMed ID: 21626079
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
Choi SH; Barsky SH; Chang HR
Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
[TBL] [Abstract][Full Text] [Related]
6. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
Cox CE; Pendas S; Cox JM; Joseph E; Shons AR; Yeatman T; Ku NN; Lyman GH; Berman C; Haddad F; Reintgen DS
Ann Surg; 1998 May; 227(5):645-51; discussion 651-3. PubMed ID: 9605656
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy.
Albo D; Ames FC; Hunt KK; Ross MI; Singletary SE; Kuerer HM
Breast Cancer Res Treat; 2003 Jan; 77(1):9-14. PubMed ID: 12602900
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of sentinel lymph node detection by methylene blue and carbon nanoparticle suspension injection in early breast cancer].
Ge J; Yan B; Cao XC
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):226-8. PubMed ID: 21575525
[TBL] [Abstract][Full Text] [Related]
12. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
[TBL] [Abstract][Full Text] [Related]
13. Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes.
Namwongprom S; Boonyaprapa S; Ekmahachai M; Vilasdechanon N; Somwangprasert A; Sumitsawan S; Taya P
Singapore Med J; 2005 Dec; 46(12):688-92. PubMed ID: 16308641
[TBL] [Abstract][Full Text] [Related]
14. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy in male breast cancer patients.
Goyal A; Horgan K; Kissin M; Yiangou C; Sibbering M; Lansdown M; Newcombe RG; Mansel RE; Chetty U; Ell P; Fallowfield L; Kissin M;
Eur J Surg Oncol; 2004 Jun; 30(5):480-3. PubMed ID: 15135473
[TBL] [Abstract][Full Text] [Related]
16. Sentinel node biopsy in ductal carcinoma in situ patients.
Pendas S; Dauway E; Giuliano R; Ku N; Cox CE; Reintgen DS
Ann Surg Oncol; 2000; 7(1):15-20. PubMed ID: 10674443
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.
Babiera GV; Delpassand ES; Breslin TM; Ross MI; Ames FC; Singletary SE; Kuerer HM; Feig BW; Meric-Bernstam F; Hunt KK
Clin Nucl Med; 2005 Jan; 30(1):11-5. PubMed ID: 15604959
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
[TBL] [Abstract][Full Text] [Related]
19. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes.
McMasters KM; Wong SL; Tuttle TM; Carlson DJ; Brown CM; Dirk Noyes R; Glaser RL; Vennekotter DJ; Turk PS; Tate PS; Sardi A; Edwards MJ
Ann Surg; 2000 May; 231(5):724-31. PubMed ID: 10767794
[TBL] [Abstract][Full Text] [Related]
20. The effect of radiocolloid preference on major parameters in sentinel lymph node biopsy practice in breast cancer.
Yararbas U; Argon AM; Yeniay L; Zengel B; KapkaƧ M
Nucl Med Biol; 2010 Oct; 37(7):805-10. PubMed ID: 20870155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]